Lupin, Zydus Lifesciences ink licensing and supply pact for

Saroglitazar Mg, approved by the DCGI, is an innovative drug from Zydus to treat chronic liver diseases, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steato Hepatitis (NASH).

Related Keywords

India , Nilesh Gupta , Sharvil Patel , Lupin Ltd , Zydus Lifesciences Ltd , Managing Director Nilesh Gupta , Managing Director Sharvil Patel , Lupin , Zydus Lifesciences , Saroglitazar Mg , Cgi , Non Alcoholic Fatty Liver Disease Nafld , On Alcoholic Steato Hepatitis Nash , ,